Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)

48.25 -0.85 (-1.73%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist

Price and Volume

Volume	699,894
Open	48.81
Bid (Size)	36.63 (100)
Ask (Size)	55.00 (100)
Prev. Close	49.10
Today's Range	47.94 - 49.04
52wk Range	29.16 - 57.65
Shares Outstanding	53,145,884
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Unprofitable Stocks We Steer Clear Of

January 21, 2026

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗

January 15, 2026

Via Chartmill

Performance

YTD	-2.5%	-2.5%
1 Month	-6.8%	-6.8%
3 Month	-8.7%	-8.7%
6 Month	+43.7%	+43.7%
1 Year	+24.9%	+24.9%

More News

Regencell Bioscience (RGC) Stumbles into 2026: 8% Year-End Slide Sparks Technical Caution

January 01, 2026

Via MarketMinute

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

3 Low-Volatility Stocks We’re Skeptical Of

December 31, 2025

Via StockStory

3 of Wall Street’s Favorite Stocks That Concern Us

December 22, 2025

Via StockStory

Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗

December 19, 2025

Via Stocktwits

Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back ↗

December 15, 2025

Via The Motley Fool

1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down

December 14, 2025

Via StockStory

3 Stocks Under $50 That Concern Us

December 11, 2025

Via StockStory

3 Unprofitable Stocks We Find Risky

December 03, 2025

Via StockStory

Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference

December 03, 2025

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds

November 23, 2025

Via StockStory

Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 21, 2025

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)

November 21, 2025

Via StockStory

This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why ↗

November 18, 2025

Via The Motley Fool

Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally ↗

November 18, 2025

Via The Motley Fool

3 Russell 2000 Stocks Walking a Fine Line

November 13, 2025

Via StockStory

Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London

November 12, 2025

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

5 Must-Read Analyst Questions From Supernus Pharmaceuticals’s Q3 Earnings Call

November 11, 2025

Via StockStory

Why Supernus Pharmaceuticals (SUPN) Shares Are Trading Lower Today

November 05, 2025

Via StockStory

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 05, 2025

Via Benzinga

SUPN Q3 Deep Dive: Growth Drivers Offset By Supply Constraints and Integration Costs

November 05, 2025

Via StockStory

Supernus Pharmaceuticals (NASDAQ:SUPN) Surprises With Strong Q3

November 04, 2025

Via StockStory

Supernus Announces Third Quarter 2025 Financial Results

November 04, 2025

From Supernus Pharmaceuticals, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?

Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market

What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?

The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 48.25

When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 01/23/26 04:00 PM ET

What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.56B

How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?

Supernus Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.